Catamaran Corp

CCT-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about CCT-T

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
April 4, 2016

(A Top Pick March 9/15. Up 31.7%.) (Now part of UnitedHealth.)

(A Top Pick March 9/15. Up 31.7%.) (Now part of UnitedHealth.)

John Zechner
Chairman, J. Zechner & Assoc
Price
$80.180
Owned
No
PAST TOP PICK
PAST TOP PICK
February 16, 2016

(A Top Pick March 9/15. Up 31.7%.) This was acquired.

Catamaran Corp (CCT-T)
February 16, 2016

(A Top Pick March 9/15. Up 31.7%.) This was acquired.

John Zechner
Chairman, J. Zechner & Assoc
Price
$80.180
Owned
No
PAST TOP PICK
PAST TOP PICK
December 29, 2015

(A Top Pick Jan 2/15. Up 30.5%.)

Catamaran Corp (CCT-T)
December 29, 2015

(A Top Pick Jan 2/15. Up 30.5%.)

Robert McWhirter
President, Selective Asset Management
Price
$80.180
Owned
No
PAST TOP PICK
PAST TOP PICK
November 3, 2015

(A Top Pick Oct 21/14. Up 71.32%.) Unitedhealth (UNH-N) took this out for a nice healthy premium.

Catamaran Corp (CCT-T)
November 3, 2015

(A Top Pick Oct 21/14. Up 71.32%.) Unitedhealth (UNH-N) took this out for a nice healthy premium.

John Zechner
Chairman, J. Zechner & Assoc
Price
$80.180
Owned
No
PAST TOP PICK
PAST TOP PICK
August 5, 2015

(A Top Pick Aug 13/14. Up 63.47%.) This company was acquired. Had thought the business was undervalued and that there was an opportunity to grow the business and the chance that they could be acquired.

Catamaran Corp (CCT-T)
August 5, 2015

(A Top Pick Aug 13/14. Up 63.47%.) This company was acquired. Had thought the business was undervalued and that there was an opportunity to grow the business and the chance that they could be acquired.

John Wilson
CEO; Co-CIO & Sr Portfolio Manager, Sprott Asset Management
Price
$80.180
Owned
No
COMMENT
COMMENT
April 15, 2015

United Health has made an offer for the stock. He waited a few weeks to see if another offer would come through. What bothered him about the deal is that this would be dead money until the deal closed. To have a name sitting there going sideways for the next 5-6 months would not have been very beneficial to the performance in his portfolio. United Health is a phenomenal company, and you couldn’t have asked for a better name to be taking this over. There might be something to look for, in how they treat it from a tax perspective. There is always some risk of an antitrust situation or some other regulatory situation. He doesn’t think the deal will fall apart.

Catamaran Corp (CCT-T)
April 15, 2015

United Health has made an offer for the stock. He waited a few weeks to see if another offer would come through. What bothered him about the deal is that this would be dead money until the deal closed. To have a name sitting there going sideways for the next 5-6 months would not have been very beneficial to the performance in his portfolio. United Health is a phenomenal company, and you couldn’t have asked for a better name to be taking this over. There might be something to look for, in how they treat it from a tax perspective. There is always some risk of an antitrust situation or some other regulatory situation. He doesn’t think the deal will fall apart.

Mike S. Newton, CIM FCSI
Director & Portfolio Manager, Scotia Wealth Management
Price
$73.250
Owned
No
HOLD
HOLD
March 24, 2015

It seems to be holding in alright. It is still very much intact. It probably needs re-stimulating in some way because the story is a bit stale now.

Catamaran Corp (CCT-T)
March 24, 2015

It seems to be holding in alright. It is still very much intact. It probably needs re-stimulating in some way because the story is a bit stale now.

Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$61.960
Owned
Unknown
TOP PICK
TOP PICK
March 9, 2015

In this environment, he is looking for things that he thinks are not expensive and that have some growth potential. He likes the area they are in. This is basically moving healthcare and the distribution of pharmaceuticals more onto an online system like the Obama care. They throw off cash and use their cash to make acquisitions to fill in their product line. Trading at about 18-19 times forward earnings.

In this environment, he is looking for things that he thinks are not expensive and that have some growth potential. He likes the area they are in. This is basically moving healthcare and the distribution of pharmaceuticals more onto an online system like the Obama care. They throw off cash and use their cash to make acquisitions to fill in their product line. Trading at about 18-19 times forward earnings.

John Zechner
Chairman, J. Zechner & Assoc
Price
$60.880
Owned
Yes
PAST TOP PICK
PAST TOP PICK
January 14, 2015

(A Top Pick Dec 20/13. Up 16.35%.) Started as a company that wired together 25 pharmacies for the Ontario government to improve drug dispensing. Since then, they have transformed themselves into a US PBM (Pharmaceutical Benefits Manager). Companies and governments running drug plans hire them to run their drug plans for them. They negotiate good prices and get better utilization. This company is very good at what they do.

Catamaran Corp (CCT-T)
January 14, 2015

(A Top Pick Dec 20/13. Up 16.35%.) Started as a company that wired together 25 pharmacies for the Ontario government to improve drug dispensing. Since then, they have transformed themselves into a US PBM (Pharmaceutical Benefits Manager). Companies and governments running drug plans hire them to run their drug plans for them. They negotiate good prices and get better utilization. This company is very good at what they do.

Michael Decter
President & CEO, Lawrence Decter Investment Counsel
Price
$58.960
Owned
Yes
TOP PICK
TOP PICK
January 2, 2015

A pharmacy benefits management company. Basically provides transparency for companies and communities that are looking to end up reducing drug costs. They cover 350 million prescriptions each year across 32 million members. Produces significant free cash flow. Earnings are expected to grow by 21%, and then accelerate to 34% in the coming 2 quarters. Stock appears to be breaking out of a 3 years sideways trading band.

Catamaran Corp (CCT-T)
January 2, 2015

A pharmacy benefits management company. Basically provides transparency for companies and communities that are looking to end up reducing drug costs. They cover 350 million prescriptions each year across 32 million members. Produces significant free cash flow. Earnings are expected to grow by 21%, and then accelerate to 34% in the coming 2 quarters. Stock appears to be breaking out of a 3 years sideways trading band.

Robert McWhirter
President, Selective Asset Management
Price
$61.440
Owned
No
COMMENT
COMMENT
November 28, 2014

A pretty volatile stock with some pretty big swings between low $40’s and high $50’s. Until we see it break out above $60, it wouldn’t interest him. If you are trying to leg into this in the shorter term, you could use some Volatility Stops.

Catamaran Corp (CCT-T)
November 28, 2014

A pretty volatile stock with some pretty big swings between low $40’s and high $50’s. Until we see it break out above $60, it wouldn’t interest him. If you are trying to leg into this in the shorter term, you could use some Volatility Stops.

Hap (Robert) Sneddon FCSI
Chief Portfolio Manager & Founder, Castlemoore Inc.
Price
$57.770
Owned
Unknown
HOLD
HOLD
November 13, 2014

An expensive business. It is usually a 31 times PE and is now historically cheap. The overall structure of the business is set up to produce more than $500 million of free cash flow. Hold it here.

Catamaran Corp (CCT-T)
November 13, 2014

An expensive business. It is usually a 31 times PE and is now historically cheap. The overall structure of the business is set up to produce more than $500 million of free cash flow. Hold it here.

Mohsin Bashir
VP Investments, Stone Asset Management
Price
$54.860
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
November 7, 2014

(A Top Pick Dec 20/13. Up 6.8%.) There was a good deal of volatility in this, based a little bit on whether Obama care was going to create more business or turbulence in the US healthcare market. It is becoming clear now that Obama care has succeeded in its goal of additional enrolled people. Obama care has succeeded in expanding the covered population, but has not had much success in retaining costs, and this company is in the sweet spot for containing costs. Thinks coverage will continue to expand, which will drive more demand to contain drug prices, which will mean more business for this company.

Catamaran Corp (CCT-T)
November 7, 2014

(A Top Pick Dec 20/13. Up 6.8%.) There was a good deal of volatility in this, based a little bit on whether Obama care was going to create more business or turbulence in the US healthcare market. It is becoming clear now that Obama care has succeeded in its goal of additional enrolled people. Obama care has succeeded in expanding the covered population, but has not had much success in retaining costs, and this company is in the sweet spot for containing costs. Thinks coverage will continue to expand, which will drive more demand to contain drug prices, which will mean more business for this company.

Michael Decter
President & CEO, Lawrence Decter Investment Counsel
Price
$54.180
Owned
Yes
TOP PICK
TOP PICK
October 21, 2014

This is just a good growth story in healthcare management. Basically going online to manage all your pharmacies and health care needs. Obama care is driving everything to these private and public exchanges these guys own. Have been kicking out excess cash flow which has been used to make acquisitions. You are getting all of this for about a 20 multiple.

Catamaran Corp (CCT-T)
October 21, 2014

This is just a good growth story in healthcare management. Basically going online to manage all your pharmacies and health care needs. Obama care is driving everything to these private and public exchanges these guys own. Have been kicking out excess cash flow which has been used to make acquisitions. You are getting all of this for about a 20 multiple.

John Zechner
Chairman, J. Zechner & Assoc
Price
$46.800
Owned
Yes
COMMENT
COMMENT
October 14, 2014

Drug distribution to the home. A smaller player that has been very, very good at taking market share from the bigger guys. Have nice visible growth earnings over the next couple of years. In a fairly economically un-sensitive business. Thinks this is going to do quite well.

Catamaran Corp (CCT-T)
October 14, 2014

Drug distribution to the home. A smaller player that has been very, very good at taking market share from the bigger guys. Have nice visible growth earnings over the next couple of years. In a fairly economically un-sensitive business. Thinks this is going to do quite well.

Bruce Tatters
Founding Partner and CIO, Triumph Asset Management
Price
$46.000
Owned
Yes
DON'T BUY
DON'T BUY
September 18, 2014

Exchange for buying pharmaceuticals. There is a lot of risk because the contracts are really short. There are positives, but the valuation is too high. Prefers express scripts.

Catamaran Corp (CCT-T)
September 18, 2014

Exchange for buying pharmaceuticals. There is a lot of risk because the contracts are really short. There are positives, but the valuation is too high. Prefers express scripts.

Barry Schwartz
CIO & Portfolio Manager, Baskin Wealth Management
Price
$51.140
Owned
Unknown
TOP PICK
TOP PICK
August 13, 2014

Stock Price came back quite a bit this year. He has been Buying Puts to take premium out on it, so that if it went lower he could buy some more. Thinks this name has gone through the worst of it. The selling season they are going through right now is actually going quite well for them. Thinks they can use M&A to buy in smaller shops, which they have done historically in a very accretive fashion. Great cash flow.

Catamaran Corp (CCT-T)
August 13, 2014

Stock Price came back quite a bit this year. He has been Buying Puts to take premium out on it, so that if it went lower he could buy some more. Thinks this name has gone through the worst of it. The selling season they are going through right now is actually going quite well for them. Thinks they can use M&A to buy in smaller shops, which they have done historically in a very accretive fashion. Great cash flow.

John Wilson
CEO; Co-CIO & Sr Portfolio Manager, Sprott Asset Management
Price
$49.050
Owned
Yes
PAST TOP PICK
PAST TOP PICK
August 6, 2014

(A Top Pick Dec 20/13. Down 6.09%.) Quite a volatile stock. They do pharmaceutical benefit management in the US. Becoming increasingly more important with Obama Care as millions more people are going to have coverage. Good entry point.

Catamaran Corp (CCT-T)
August 6, 2014

(A Top Pick Dec 20/13. Down 6.09%.) Quite a volatile stock. They do pharmaceutical benefit management in the US. Becoming increasingly more important with Obama Care as millions more people are going to have coverage. Good entry point.

Michael Decter
President & CEO, Lawrence Decter Investment Counsel
Price
$47.650
Owned
Yes
TOP PICK
TOP PICK
August 1, 2014

Healthcare in general has seen a tremendous amount of technology spending. It needs it. The rollout of the Affordable Care act in the US is making the public and private pharmacy benefit exchanges much more valuable. Their acquisitions over the last couple of years have been ultimately accretive to earnings. On a valuation basis you are probably trading at around 20X earnings.

Catamaran Corp (CCT-T)
August 1, 2014

Healthcare in general has seen a tremendous amount of technology spending. It needs it. The rollout of the Affordable Care act in the US is making the public and private pharmacy benefit exchanges much more valuable. Their acquisitions over the last couple of years have been ultimately accretive to earnings. On a valuation basis you are probably trading at around 20X earnings.

John Zechner
Chairman, J. Zechner & Assoc
Price
$49.090
Owned
Yes
WATCH
WATCH
July 21, 2014

This was expected not to do so well and have a flattish year, but had a surprisingly very good first quarter. They are reporting in the next couple of weeks, and if they have another one the stock has room to move. Looks interesting, but a little bit risky if you buy before the earnings.

This was expected not to do so well and have a flattish year, but had a surprisingly very good first quarter. They are reporting in the next couple of weeks, and if they have another one the stock has room to move. Looks interesting, but a little bit risky if you buy before the earnings.

Bruce Campbell (1)
President, Campbell and Lee InvMngmnt
Price
$47.420
Owned
Yes
DON'T BUY
DON'T BUY
July 11, 2014

Doesn’t have any good news on this. Chart shows the stock has established a downward trend. Broke a short-term support in the last couple of days. Underperforming the market, and is below its 20 day moving average. Wait until there are positive technical signs before Buying.

Doesn’t have any good news on this. Chart shows the stock has established a downward trend. Broke a short-term support in the last couple of days. Underperforming the market, and is below its 20 day moving average. Wait until there are positive technical signs before Buying.

Don Vialoux
Research Analyst, TimingTheMarket.CA & EquityClock.COM
Price
$47.430
Owned
Unknown
DON'T BUY
DON'T BUY
May 12, 2014

Doesn’t know if they get taken out. Not an overly demanding multiple. Integration issues with some CI work. It’s on his radar.

Doesn’t know if they get taken out. Not an overly demanding multiple. Integration issues with some CI work. It’s on his radar.

James Telfser
Partner & Portfolio Manager, Aventine Management Group
Price
$46.210
Owned
No
WATCH
WATCH
May 7, 2014

Sold his holdings when he thought the valuation was too high. Had a good quarter and the stock moved up, but looking at the other companies in this space, their multiples have also come down. He would rather see a couple of quite strong quarters before stepping in.

Sold his holdings when he thought the valuation was too high. Had a good quarter and the stock moved up, but looking at the other companies in this space, their multiples have also come down. He would rather see a couple of quite strong quarters before stepping in.

Peter Imhof
Vice President & Portfolio Manager, AGF Investments Inc
Price
$44.870
Owned
No
HOLD
HOLD
May 6, 2014

Pharmacy benefits manager. He likes to adhere to a stop-loss program, but there was nothing in the numbers or any research that could explain the big downdraft the stock was having other than the environment with healthcare, Obama care, etc. Greater earnings report last week. Thinks they still have good numbers ahead of it.

Pharmacy benefits manager. He likes to adhere to a stop-loss program, but there was nothing in the numbers or any research that could explain the big downdraft the stock was having other than the environment with healthcare, Obama care, etc. Greater earnings report last week. Thinks they still have good numbers ahead of it.

Mike S. Newton, CIM FCSI
Director & Portfolio Manager, Scotia Wealth Management
Price
$44.880
Owned
Yes
BUY
BUY
May 2, 2014

(Market Call Minute.) Had a blow out quarter yesterday in the stock has gone up 7%-8%. His target is $60 in one year.

(Market Call Minute.) Had a blow out quarter yesterday in the stock has gone up 7%-8%. His target is $60 in one year.

Bruce Campbell (1)
President, Campbell and Lee InvMngmnt
Price
$46.770
Owned
Yes
BUY WEAKNESS
BUY WEAKNESS
April 28, 2014

Nervous about earnings coming out this week. There could be a miss. Likes it over the long term. They are positioned well and it will be a good growth profile going forward. This is where healthcare is going.

Catamaran Corp (CCT-T)
April 28, 2014

Nervous about earnings coming out this week. There could be a miss. Likes it over the long term. They are positioned well and it will be a good growth profile going forward. This is where healthcare is going.

John Zechner
Chairman, J. Zechner & Assoc
Price
$42.750
Owned
Yes
COMMENT
COMMENT
March 31, 2014

This gets very close to getting stopped out in his portfolio, but hasn’t quite reached that point. Feels there has been a lot of misunderstanding and confusion around a lot of things that are been happening with this company recently, causing a lot of volatility in the name. Also, with Obama care and medical issues in the US, there has been confusion about who is going to win, where does the money go, etc. Thinks the Obama mandated healthcare situation is going to bring about 30 million more customers into the pipeline. This will be quiet for a while longer, but you’ll probably start to see it creep up at some point.

Catamaran Corp (CCT-T)
March 31, 2014

This gets very close to getting stopped out in his portfolio, but hasn’t quite reached that point. Feels there has been a lot of misunderstanding and confusion around a lot of things that are been happening with this company recently, causing a lot of volatility in the name. Also, with Obama care and medical issues in the US, there has been confusion about who is going to win, where does the money go, etc. Thinks the Obama mandated healthcare situation is going to bring about 30 million more customers into the pipeline. This will be quiet for a while longer, but you’ll probably start to see it creep up at some point.

Mike S. Newton, CIM FCSI
Director & Portfolio Manager, Scotia Wealth Management
Price
$49.460
Owned
Yes
BUY
BUY
March 10, 2014

Has taken a pounding after a big run. A big beneficiary of Obama care in the US. Not inexpensive but as more Americans get insured under Obama care, the market for this company will grow. Very good at what they do.

Catamaran Corp (CCT-T)
March 10, 2014

Has taken a pounding after a big run. A big beneficiary of Obama care in the US. Not inexpensive but as more Americans get insured under Obama care, the market for this company will grow. Very good at what they do.

Michael Decter
President & CEO, Lawrence Decter Investment Counsel
Price
$50.540
Owned
Yes
HOLD
HOLD
January 20, 2014

There is a critical level at $46-$47 and the stock must not break below that level. Consider a stop loss.

Catamaran Corp (CCT-T)
January 20, 2014

There is a critical level at $46-$47 and the stock must not break below that level. Consider a stop loss.

Ron Meisels
President, P & C Holdings
Price
$54.900
Owned
Unknown
COMMENT
COMMENT
January 15, 2014

Pharmacy benefit management. With the new healthcare act coming into the US there is room for them to grow over the longer term. Ranks in the middle of the pack in his process.

Catamaran Corp (CCT-T)
January 15, 2014

Pharmacy benefit management. With the new healthcare act coming into the US there is room for them to grow over the longer term. Ranks in the middle of the pack in his process.

Bruce Campbell (2)
President & Portfolio Manager, Stone Castle Investment Management Inc.
Price
$54.320
Owned
No
Showing 1 to 30 of 143 entries